{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:27:55Z","timestamp":1789021675343,"version":"build-2803163510"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T00:00:00Z","timestamp":1568246400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T00:00:00Z","timestamp":1568246400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s11916-019-0823-8","type":"journal-article","created":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T05:03:13Z","timestamp":1568264593000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Preventative Treatment of Episodic Migraine in Adults"],"prefix":"10.1007","volume":"23","author":[{"given":"T.","family":"Dorosch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. A.","family":"Ganzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Seifan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,12]]},"reference":[{"issue":"3","key":"823_CR1","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/head.12074","volume":"53","author":"TA Smitherman","year":"2013","unstructured":"Smitherman TA, Burch R, Sheikh H, Loder E. The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies. Headache: The Journal of Head and Face Pain. 2013;53(3):427\u201336.","journal-title":"Headache: The Journal of Head and Face Pain"},{"issue":"1","key":"823_CR2","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jpain.2016.10.005","volume":"18","author":"AD Raval","year":"2017","unstructured":"Raval AD, Shah A. National trends in direct health care expenditures among US adults with migraine: 2004 to 2013. J Pain. 2017;18(1):96\u2013107.","journal-title":"J Pain"},{"issue":"1","key":"823_CR3","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s10072-008-0901-x","volume":"29","author":"AM Rapoport","year":"2008","unstructured":"Rapoport AM. Acute and prophylactic treatments for migraine: present and future. Neurol Sci. 2008;29(1):110\u201322.","journal-title":"Neurol Sci"},{"issue":"5","key":"823_CR4","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.1468-2982.2008.01555.x","volume":"28","author":"S Silberstein","year":"2008","unstructured":"Silberstein S, Tfelt-Hansen P, Dodick DW, Limmroth V, Lipton R, Pascual J, et al. Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults. Cephalalgia. 2008;28(5):484\u201395.","journal-title":"Cephalalgia."},{"issue":"2","key":"823_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.4103\/0253-7613.93840","volume":"44","author":"R Nandha","year":"2012","unstructured":"Nandha R, Singh H. Renin angiotensin system: a novel target for migraine prophylaxis. Indian J Pharm. 2012;44(2):157.","journal-title":"Indian J Pharm"},{"issue":"2","key":"823_CR6","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.pneurobio.2009.07.005","volume":"89","author":"F Galletti","year":"2009","unstructured":"Galletti F, Cupini LM, Corbelli I, Calabresi P, Sarchielli P. Pathophysiological basis of migraine prophylaxis. Prog Neurobiol. 2009;89(2):176\u201392.","journal-title":"Prog Neurobiol"},{"issue":"6","key":"823_CR7","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1177\/147323000903700602","volume":"37","author":"M Burnier","year":"2009","unstructured":"Burnier M. Telmisartan: a different angiotensin II receptor blocker protecting a different population? J Int Med Res. 2009;37(6):1662\u201379.","journal-title":"J Int Med Res"},{"issue":"7","key":"823_CR8","doi-asserted-by":"publisher","first-page":"E269","DOI":"10.1503\/cmaj.081657","volume":"182","author":"T. Pringsheim","year":"2010","unstructured":"Pringsheim T, Davenport WJ, Becker WJ. Prophylaxis of migraine headache. Cmaj. 2010;182(7):E269\u2013E276. Epub 2010\/02\/18.","journal-title":"Canadian Medical Association Journal"},{"key":"823_CR9","unstructured":"U.S. Preventive Services Task Force. Guildeline to clinical preventive services. Baltimore. p. 1989."},{"issue":"7","key":"823_CR10","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1177\/0333102413515348","volume":"34","author":"LJ Stovner","year":"2014","unstructured":"Stovner LJ, Linde M, Gravdahl GB, Tronvik E, Aamodt AH, Sand T, et al. A comparative study of candesartan versus propranolol for migraine prophylaxis: a randomised, triple-blind, placebo-controlled, double cross-over study. Cephalalgia. 2014;34(7):523\u201332.","journal-title":"Cephalalgia."},{"issue":"9","key":"823_CR11","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/j.1468-2982.2008.01825.x","volume":"29","author":"H Diener","year":"2009","unstructured":"Diener H, Gendolla A, Fruersenger A, Evers S, Straube A, Schumacher H, et al. Telmisartan in migraine prophylaxis: a randomized, placebo-controlled trial. Cephalalgia. 2009;29(9):921\u20137.","journal-title":"Cephalalgia."},{"issue":"1","key":"823_CR12","first-page":"72","volume":"4","author":"SA Sonbolestan","year":"2013","unstructured":"Sonbolestan SA, Heshmat K, Javanmard SH, Saadatnia M. Efficacy of enalapril in migraine prophylaxis: a randomized, double-blind, placebo-controlled trial. Int J Prev Med. 2013;4(1):72.","journal-title":"Int J Prev Med"},{"issue":"1","key":"823_CR13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/jama.289.1.65","volume":"289","author":"E Tronvik","year":"2003","unstructured":"Tronvik E, Stovner LJ, Helde G, Sand T, Bovim G. Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. JAMA : J Am Med Assoc. 2003;289(1):65\u20139.","journal-title":"JAMA : J Am Med Assoc"},{"issue":"3","key":"823_CR14","first-page":"289","volume":"18","author":"H-J Park","year":"2013","unstructured":"Park H-J, Lee S-T, Kim M. Inhibitory control of angiotensin-converting enzyme by ramipril in migraine. Neurology Asia. 2013;18(3):289\u201391.","journal-title":"Neurology Asia"},{"issue":"6","key":"823_CR15","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/j.1468-1331.2007.01764.x","volume":"14","author":"S Schuh-Hofer","year":"2007","unstructured":"Schuh-Hofer S, Flach U, Meisel A, Israel H, Reuter U, Arnold G. Efficacy of lisinopril in migraine prophylaxis\u2013an open label study. Eur J Neurol. 2007;14(6):701\u20133.","journal-title":"Eur J Neurol"},{"issue":"2 Suppl 2","key":"823_CR16","first-page":"S1","volume":"39","author":"T Pringsheim","year":"2012","unstructured":"Pringsheim T, Davenport W, Mackie G, Worthington I, Aub\u00e9 M, Christie SN, et al. Canadian Headache Society guideline for migraine prophylaxis. Can J Neurol Sci. 2012;39(2 Suppl 2):S1\u201359.","journal-title":"Can J Neurol Sci"},{"issue":"9","key":"823_CR17","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1007\/s11606-013-2433-1","volume":"28","author":"TA Shamliyan","year":"2013","unstructured":"Shamliyan TA, Choi J-Y, Ramakrishnan R, Miller JB, Wang S-Y, Taylor FR, et al. Preventive pharmacologic treatments for episodic migraine in adults. J Gen Intern Med. 2013;28(9):1225\u201337.","journal-title":"J Gen Intern Med"},{"issue":"5","key":"823_CR18","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s10072-017-2854-4","volume":"38","author":"K Ikeda","year":"2017","unstructured":"\u2022 Ikeda K, Hanashiro S, Ishikawa Y, Sawada M, Kyuzen M, Morioka H, et al. Treatment with telmisartan, a long-acting angiotensin II receptor blocker, prevents migraine attacks in Japanese non-responders to lomerizine. Neurol Sci. 2017;38(5):827\u201331 This manuscript demonstrates the efficacy of telmisartan for the treatment of migraines.","journal-title":"Neurol Sci"},{"issue":"1","key":"823_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10072-011-0526-3","volume":"32","author":"P Barbanti","year":"2011","unstructured":"Barbanti P, Aurilia C, Egeo G, Fofi L. Migraine prophylaxis: what is new and what we need? Neurol Sci. 2011;32(1):111.","journal-title":"Neurol Sci"},{"issue":"8","key":"823_CR20","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1111\/head.12878","volume":"56","author":"RB Lipton","year":"2016","unstructured":"Lipton RB, Manack Adams A, Buse DC, Fanning KM, Reed ML. A comparison of the chronic migraine epidemiology and outcomes (CaMEO) study and American migraine prevalence and prevention (AMPP) study: demographics and headache-related disability. Headache: The Journal of Head and Face Pain. 2016;56(8):1280\u20139.","journal-title":"Headache: The Journal of Head and Face Pain"},{"issue":"7651","key":"823_CR21","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1136\/bmj.39490.551019.BE","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Sch\u00fcnemann HJ. What is \u201cquality of evidence\u201d and why is it important to clinicians? BMJ (Clinical research ed). 2008;336(7651):995\u20138.","journal-title":"BMJ (Clinical research ed)"},{"issue":"1","key":"823_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10072-009-0055-5","volume":"30","author":"F Moschiano","year":"2009","unstructured":"Moschiano F, D\u2019Amico D, Bussone G. Migraine prophylaxis: key points for the practising clinician. Neurol Sci. 2009;30(1):33\u20137.","journal-title":"Neurol Sci"},{"issue":"4","key":"823_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11940-016-0397-2","volume":"18","author":"RB Halker","year":"2016","unstructured":"\u2022 Halker RB, Starling AJ, Vargas BB, Schwedt TJ. ACE and ARB agents in the prophylactic therapy of migraine-how effective are they? Curr Treat Options Neurol. 2016;18(4):15 This paper provides evidence based on clinical trials that ACE inhibitors and ARBs are effective and generally well tolerated when used for migraine prophylaxis.","journal-title":"Curr Treat Options Neurol"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-019-0823-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11916-019-0823-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-019-0823-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T19:47:41Z","timestamp":1599767261000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11916-019-0823-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,12]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["823"],"URL":"https:\/\/doi.org\/10.1007\/s11916-019-0823-8","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,12]]},"assertion":[{"value":"12 September 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no conflicts of interest relevant to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"85"}}